|
|
 |
|
|
 |
|
Diabetes Research
Institute Designated Islet Cell Transplant Center by NIH |
 |
|
|
 |
|
|
 |
|
|
 |
|
|
 |
|
|
 |
|
 |
|
| |
| Stimulating Sight |
| |
 |
|
  |
Diabetes Research Institute
Designated Islet Cell Transplant Center by NIH
Road to a Cure
he
Diabetes Research Institute (DRI) has been selected as one of only
five centers worldwide to receive funding from the National Institutes
of Health (NIH) for clinical islet transplant trials in patients with
type 1 diabetes. The NIH plans to award about $75 million over five
years to a network that includes three centers in the United States
and two
centers abroad, with a data coordinating center at the University of
Iowa.
“This new, unprecedented funding from
NIH will allow the DRI to continue and expand our team effort to
develop successful islet transplant strategies,
without potentially harmful anti
rejection drugs,” says Camillo Ricordi, M.D., Stacy Joy Goodman
Professor of Surgery and scientific director of the DRI. “Our
long-term goal will be to develop safe and effective anti-rejection
strategies and eventually immune tolerance to
the transplanted insulin-producing cells so that patients will no
longer require a lifetime of anti-rejection
drugs.”
It’s estimated that more than 17 million Americans have diabetes—and
more than one million of those have the type 1 form of the disease.
Type 1 diabetes is usually diagnosed in children and young adults
and is often referred to as juvenile diabetes.
In islet transplantation, islets are extracted
from the pancreas of a deceased donor and infused into a patient
with type 1
diabetes through
the portal vein of the liver. In successful transplants,
the cells lodge in the liver’s small blood vessels and begin
producing insulin. The procedure is seen as having the most potential
as
a treatment for type 1 diabetes.
The DRI has already designed and submitted
new clinical trial protocols as part of the funding process in the
NIH network.
Back
to top
|
 |
|
 |
Gwendolyn B. Scott First Recipient of
a
New Children’s Research Award
wendolyn
B. Scott, M.D., professor of pediatrics and director of the Division of Pediatric
Infectious Disease and Immunology at the Miller School of Medicine, decided
to specialize in infectious disease because she liked to see patients get well.
“You
give them antibiotics, and they get better,” Scott says.
Then came the HIV/AIDS epidemic. Scott saw some of the very first
children with AIDS early in 1981. “The babies died very early—there
was rapid disease progression in 20 percent of these infants.”
But through the efforts of Scott and her colleagues
in the Miller School of Medicine, the transmission rate of HIV/AIDS
from mother to infant has declined to less than one percent. And
her continuing research efforts in the treatment of pediatric HIV/AIDS
have resulted in her selection as the first recipient of the Micah
Batchelor Award for Excellence in Children’s Health Research.
As a pediatric infectious disease specialist
at UM/Jackson Memorial Medical Center, Scott cares for the largest
number of pediatric HIV patients seen at a single center in the
country. With the Micah Batchelor Award, she and her team will
develop new ways to prevent the transmission of the virus from
mother to child.
The late George E. Batchelor, a renowned aviation
entrepreneur and philanthropist, established the Micah Batchelor
Award for Excellence in Children’s Health Research in memory
of his grandson, Micah. The award was started with a $5 million
endowment; each year at least $300,000 will be awarded to one University
of Miami scientist conducting research in children’s diseases
and working in the Batchelor Children’s Research Institute.
This is one of the largest awards nationally for children’s
health research.
Batchelor’s longtime financial commitment
to the University of Miami Miller School of Medicine, and in particular
the Department of Pediatrics, was largely responsible for the establishment
of the Batchelor Children’s Research Institute.
Back to top |
|
 |
|
 |
| Helping
alzheimer’s patients preserve functional
skills
Mind Training
 hen
patients are first diagnosed with the early signs of dementia, especially
Alzheimer’s disease, they are often treated with medication that
can enhance the function of the hippocampus, the memory center of the
brain. That can delay dementia—but it can’t prevent it. Researchers
at the Miller School of Medicine wondered whether they could train
other parts of the brain that are
spared by early Alzheimer’s to enhance
memory and other skills, and they devised a training program to find out.
They call it cognitive rehabilitation.
“These methods are all ways of targeting regions of the brain other than
the hippocampus and to rely on areas of the brain that still have full function,” says
David Loewenstein, Ph.D., director of research and neuropsychology for Mount
Sinai’s Wien Center and professor of psychiatry and behavioral sciences
at the Miller School of Medicine. In Alzheimer’s, cholinesterase inhibitors
keep acetylcholine in the neuronal synapses in the hippocampus, which can help—but
only for a year or two. Loewenstein considers that a window of opportunity.
“The area of the brain responsible for motor
movements is also responsible for motor memory, so we can target that
area and other areas for implicit or procedural
memory,” says Loewenstein. He worked closely with Sara Czaja, Ph.D.,
director of the Center for Research and Education on Aging and Technology
Enhancement,
and assistant professor Amarilis Acevedo, Ph.D., cognitive rehabilitation
co-developer, who led the work among Spanish-speaking patients. The results
of their three-year
study were published in the July-August 2004 issue of the American
Journal of Geriatric Psychiatry.
They assigned 44 patients taking a cholinesterase inhibitor into two
groups: one receiving minimal mental stimulation, the other receiving
24 weekly
sessions of intensive cognitive rehabilitation.
“People who participated in the rehabilitation sessions had far greater
cognitive skill gains than the other group,” Loewenstein says.
The endpoint in the research is to help patients keep their functional
skills.
“We may have medications in the future that could stop progression so we
want to give patients a bridge to maintain the functionality that they have,” he
says . “Now instead of just giving someone a diagnosis, you can
also tell them there is something they can do about it.”
Back to top
|
 |
|
|
 |
Interventions for Spinal Cord Injury Patients
dvances
in medicine sometimes yield unintended consequences. Case in point:
Aging with a spinal cord injury is a relatively new phenomenon because
more people are suffering spinal cord injuries or disabilities later
in life, and those injured at a young age are living longer.
“Older persons with a spinal cord injury
or disability face the dual challenges of injury-related disability
and age-related declines in functioning,” says
Sara Czaja, Ph.D., professor of psychiatry and behavioral sciences
and co-director of the Center on Aging. “Also, people who provide
support to these patients face multiple and often extreme challenges.” Czaja and her team at UM, together with colleagues
at the University of Pittsburgh, have begun recruiting patients after
being awarded a
five-year, $3.4 million grant from the National Institute of Nursing
Research. They
will study how an innovative, multi-component psycho-social technology
intervention can help spinal cord-injured patients and the people
who care for them.
The 400 participants will have greater access
to community, government, and health care resources, enhanced social
support, and will learn
strategies that may help
with physical and emotional health, stress, communication, and socialization.
The program is tailored to the participant’s needs.
Helping these patients live longer is only half
the task.
“Our goal,” says Czaja, “is really to increase the quality
of life and independence of these people.”
Back to top |
 |
 |
 |
Medical Students Start at Satellite Campus in Boca
Raton
Meeting Statewide Needs
call
to train more physicians in the state of Florida was answered in part
this fall as 16 students began attending the University of Miami Miller
School of Medicine at Florida Atlantic University.
The 16 students are part of the Miller School
of Medicine’s largest-ever
freshman class. They will complete the first two years of their medical
curriculum at FAU’s Boca Raton campus before transferring to Miami
to complete years three and four at the UM/ Jackson Memorial Medical
Center campus.
Ainel Boonprakong appreciates being part of
that first class. “Students
have so many more opportunities to interact with the faculty because
it’s such a small class size,” says Boonprakong.
“What I like about it is that you feel you have your own piece of the medical
school. You have a place, you have a study, you have your own desk. It’s
a very homey feeling. Medical school is very rigorous—having the feeling
that you belong is going to make it go smoother.”
The FAU program was created as state lawmakers
became aware of a developing shortage of locally trained physicians.
By combining forces, FAU, a public
university
with more than 25,000 undergraduate and graduate students, and the Miller
School of Medicine enabled the state to fulfill its commitment to expand
medical education
without the expense of creating new medical schools. Building on that
unique educational partnership, the Miller School of Medicine and FAU
also entered
into talks with Boca Raton Community Hospital about becoming a community
teaching hospital for the school. “The affiliation among the Miller School of Medicine,
FAU, and Boca Raton Community Hospital would give our students invaluable patient
care experience from the very beginning,” says John G. Clarkson, M.D. ’68,
senior vice president for medical affairs and dean of the University of Miami
Miller School of Medicine. “This is a win-win-win situation, not only for
the three institutions but also for southern Palm Beach County.”
Back to top |
 |
|
|
 |
UM Leads HIV Study in India
ince
the first HIV infection in India surfaced in 1987, the number
of cases has risen at an alarming rate. The United Nations
estimates five million Indians were HIV positive last year,
a number that may be doubling every 18 months. Experts believe
India could eventually surpass Africa in the number of HIV
cases. And now the University of Miami Miller School of Medicine
is doing its part to help stem the rising
epidemic.
Mahendra Kumar, Ph.D.,
professor of psychiatry and behavioral sciences, has teamed
up with investigators in his native India to help them
find ways to handle the spreading infection.
Funded by the National Institutes of Health, Kumar’s study is looking
at the neurological and neuropsychological effects of HIV.
The UM-led study is
being conducted in Bangalore, India, with scientists from India’s National
Institute of Mental Health and Neurosciences, as well as in Chandigarh
in northern India. The researchers will follow more
than 200 patients over three years to evaluate neurological and neurocognitive
impairments associated with HIV-related dementia and minor cognitive-motor
disorders resulting from the virus entering the central nervous system. “Once we
pinpoint the prevalence of neurologic problems among the HIV infected, a health
policy can be instituted that may help design interventions for the infected
individuals,” Kumar explains.
One of the study’s
long-range goals is to strengthen the research capacity of scientists
in India.
The UM investigators
have extensive experience in HIV
research, while very little of this type of research has been carried out
in India.
Back to top
|
|
 |
|
 |
|
News, Accomplishments, and Achievements in the Miller
School of Medicine
Making Headlines
Learning
without facts
U.S. News & World Report
July 26, 2004
David Loewenstein, Ph.D., professor of psychiatry and behavioral sciences,
was interviewed about his newly published study that showed Alzheimer’s
patients in the early stages of the disease can still learn new skills.
His research was also reported on Miami television stations WTVJ, WFOR,
and WPLG, and in The Miami Herald, Sun-Sentinel, Los Angeles Times, and
WebMD
.
Fitness through
the ages
The Miami Herald
July 27, 2004
Five Miller School of Medicine physicians were featured in an extensive
article about keeping trim for a lifetime. Robert Schwartz, M.D., Carla
Lupi, M.D., Larry Friedman, M.D., Silvina Levis, M.D., and Ronald Goldberg,
M.D., were each featured in their area of expertise.
Maggots make
medical comeback
Associated Press
August 3, 2004
Robert Kirsner, M.D., director of the UM Wound Center, talked about his
research using the wriggly little creatures on patients where conventional
therapy alone wasn’t enough. It has been a year since the Food
and Drug Administration approved the use of the insects to clean wounds.
Prospects improve
for those with spinal cord injuries
USA Today
August 17, 2004
The Miami Project to Cure Paralysis was prominently featured in a USA
Today article on research into paralysis. Scientific Director W. Dalton
Dietrich, Ph.D., said that “in the last five years, it has never
been more exciting in terms of the knowledge we’re obtaining.” Researcher
Edelle Field-Fote, Ph.D., was interviewed about her study, which is evaluating
several methods of locomotion training. “Humans have evolved in
a way that requires the brain to turn those circuits on, but by retraining
the circuits in the spinal cord, it might be possible to enhance motion,
even when signals from the brain are blocked.”
Hurricane stress
September 9-13, 2004
Stress was at a record level in South Florida when Hurricane Ivan threatened,
since it was the third hurricane to do so in just one month. Daniel Armstrong,
Ph.D., professor and vice chair of the Department of Pediatrics and director
of the Mailman Center for Child Development, and Alan Delamater, Ph.D.,
professor of pediatrics and psychology and director of the Psychology
Division at the Mailman Center, became voices of calm for South Florida.
They were quoted in publications including USA Today, The
Miami Herald,
Los Angeles Times, and The Palm Beach Post, and appeared on programs
aired by CBS, CNN, and MSNBC.
|
Back to top
|
 |
 |
 |
Policy Forum Raises Critical Questions
The Presidency and Health Care fter
the dust—and the rhetoric—of the election settle, the president
of the United States is going to have to deal with a health care system
that needs a serious shot in the arm.
That was the message of Why Care, Why Vote?
What’s at Stake for
Health in Election 2004, a forum held in October at the Miller School
of Medicine. Co-sponsored by the Henry J. Kaiser Family Foundation in
honor of Leila Applebaum, a long-time supporter of the Miller School
of Medicine, the event brought together renowned health care policy experts
as part of the University’s Presidential Debate series. Moderating
and joining the discussion were University President Donna E. Shalala
and CNN Medical Correspondent Sanjay Gupta, M.D. The audience was filled
with a rapt group of first- and second-year medical students.
Diane Rowland, Sc.D., executive vice president
of the Henry J. Kaiser Family Foundation and executive director of
the Kaiser Commission on
Medicaid and the
Uninsured, gave an overview of the critical issues facing the American health
care system.
Judy Feder, Ph.D., professor and dean of the
Georgetown Public Policy Institute, Georgetown University, and Bruce
Vladeck, Ph.D., professor of health policy
and geriatrics at the Mount Sinai School of Medicine, then discussed—or rather,
dissected—the presidential candidates’ health care policy positions.
What became clear from the speakers was that
no matter which policy prevails, the steadily increasing numbers of
uninsured and elderly will have an unprecedented
impact on the training and practices of these future physicians.
After the speakers finished, students asked
questions on issues including the disparity between regular health
and mental health coverage and the
prohibitive cost of malpractice insurance.
Back to top
|
 |
 |
| |
Stimulating Sight
 here
is new hope for the estimated 1.5 million stroke and traumatic
brain injury patients in the United States who have major vision
problems that affect their daily life. Physicians in the Department
of Neurology and at Bascom Palmer Eye Institute are among the first
in the country to offer patients a new computer-based therapy for
vision loss. The treatment, NovaVision VRT, was developed by NovaVision,
Inc. of Boca Raton and approved by the U.S. Food and Drug Administration
in 2003.
VRT (Vision Restoration
Therapy) is based on the principle of neuroplasticity—the
ability of partially damaged neurons in the brain to compensate
for injury and adjust their activity in response to stimulation
from
the environment. After a stroke or brain injury, an area of residual
vision exists between regions within the brain’s vision-processing
areas. Within this zone, there are areas that can be improved using
precise patterns of stimulation.
Here’s how the therapy works: A patient focuses on a fixation
point displayed on a specially designed computerized device. During
each session, specifically engineered stimuli are applied to the
identified areas that show potential for recovery. Repeated exposure
to these stimuli over a period of six months activates neurons and
helps improve vision.
“It was once thought
that after a brief period of spontaneous recovery, improvement
in visual function ended. With this innovative technology
based on the principle of neuroplasticity, we may now have
the potential to improve vision and quality of life for many stroke
and brain injury
patients,” says Jose G. Romano, M.D., associate professor
of neurology.
After an initial session
and training, patients can perform the therapy at home.
Back to top |
|
 |
 |
 |
Photography
by John Zillioux, Donna Victor, Pyramid Photographics,and David Southerland
Illustrations
byAndrew Faulkner and Michael S. Klein
|
|
|
|
 |
|
|
 |
|
|
 |
 |
|
|
 |